(Q53250371)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21541974%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Anti-angiogenic effects and mechanism of prazosin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21541974%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

main subject

angiogenesis inhibitor

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21541974%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Hong-Jeng Yu

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21541974%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Chun-Hou Liao

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21541974%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Shih-Chieh Chueh

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21541974%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

6 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21541974%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21541974%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21541974%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21541974%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

976-984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21541974%20AND%20SRC:MED&resulttype=core&format=json

Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasia

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

Assessment of alpha1-adrenoceptor antagonists in benign prostatic hyperplasia based on the receptor occupancy theory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

Novel therapeutic targets in lung cancer: Inhibitor of apoptosis proteins from laboratory to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

The role of alpha-blockers in the management of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

The alpha1-adrenergic receptor antagonist doxazosin inhibits EGFR and NF-kappaB signalling to induce breast cancer cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

Doxazosin inhibits proliferation and migration of human vascular smooth-muscle cells independent of alpha1-adrenergic receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

Doxazosin inhibits monocyte chemotactic protein 1-directed migration of human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

Alpha1-adrenergic receptor antagonists: novel therapy for pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

Doxazosin inhibits retinoblastoma protein phosphorylation and G(1)-->S transition in human coronary smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

Inhibition of mitogenic signaling and induction of apoptosis in human bladder smooth muscle cells treated with doxazosin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

Novel quinazoline-based compounds impair prostate tumorigenesis by targeting tumor vascularity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

Endothelial alpha1-adrenoceptors regulate neo-angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313

Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21313